You are receiving this pop-up because this is the first time you are visiting our site. If you keep getting this message, please enable cookies in your browser.
You are using software which is blocking our advertisements (adblocker).
As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site. Thanks!
You are receiving this pop-up because this is the first time you are visiting our site. If you keep getting this message, please enable cookies in your browser.
Bangladesh: Regulatory approval sought for GMO late blight resistant potato
Late blight still affects more than 3 million hectares of potato crops globally and causes economic losses estimated at $ 2.75 billion a year, according to the International Potato Center (CIP). Yet scientists in Bangladesh have successfully field-tested a genetically modified (GMO) potato resistant to the devastating disease and once the last trial is over in February, the Bangladesh Agricultural Research Institute (BARI) will approach regulators for approval of the potato. Once released, the potato will be farmers' answer to late blight, BARI officials have said.
In Bangladesh, BARI is developing late blight resistant potato in cooperation with the Agricultural Biotechnology Support Project II (ABSPII), a USAID-funded consortium of public and private sector institutions supporting scientists, regulators, extension workers, farmers and the general public in developing countries to make informed decisions about agricultural biotechnology.
Breeders involved in developing the GM potato since 2006 at BARI said the RB gene was taken from wild potato varieties and was infused into a potato variety called Katahdin in the United States. They said it was crossed with Diamant and Cardinal -- two popular potato varieties in Bangladesh.
Md Abu Kawochar, scientific officer of BARI's Tuber Crops Research Centre (TCRC), said, "Since 2006 we've exhausted all trials from laboratory to greenhouse to field tests to multi-location tests. Now the regulatory trial is going on in six sites in the country and all these have shown positive results."
Abu Kawochar said nutrient composition test, toxicology test, and efficacy test -- all were complete. "We'll be able to apply for variety release after the current regulatory trial is over."